Literature DB >> 1976004

Auditing community screening for undescended testes.

R C Tamhne1, S N Jarvis, A J Waterston.   

Abstract

Different ways of auditing screening for undescended testes, using Hospital Activity Analysis data, hospital case notes, and community/general practice records are described. The cumulative orchidopexy rate per 1000 male births in successive birth cohorts is a simple tool for monitoring trends within a health district. Information gained from community/general practice records is valuable in highlighting problem areas in screening, such as the lack of clear diagnostic criteria and referral pathways.

Mesh:

Year:  1990        PMID: 1976004      PMCID: PMC1792507          DOI: 10.1136/adc.65.8.888

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Cryptorchidism: a renewed plea.

Authors:  M C Bishop; R H Whitaker
Journal:  Br Med J       Date:  1979-02-10

2.  A study of the sources of delay in the diagnosis and treatment of undescended testicle.

Authors:  A R Boggis; R J Rowlatt
Journal:  J R Coll Gen Pract       Date:  1984-08

3.  Apparent doubling of frequency of undescended testis in England and Wales in 1962-81.

Authors:  C Chilvers; M C Pike; D Forman; K Fogelman; M E Wadsworth
Journal:  Lancet       Date:  1984-08-11       Impact factor: 79.321

4.  The undescended testicle: a continuing failure.

Authors:  H Reece-Smith; C U Moisey
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-02
  4 in total
  3 in total

1.  Auditing community screening for undescended testes.

Authors:  R A Hirasing; R P Boontje
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Screening of testicular descent in older boys is worthwhile: an observational study.

Authors:  Andrew G Neilson; Gregor M Walker
Journal:  Br J Gen Pract       Date:  2011-03       Impact factor: 5.386

3.  Late diagnosis of cryptorchidism: a failure of medical screening?

Authors:  A Sarmah
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.